Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
29 févr. 2024 07h30 HE
|
Arbutus Biopharma Corporation
On-track to report key clinical data in 2024 from two on-going Phase 2a clinical trials with imdusiran and the Phase 1a/1b clinical trial with AB-101 Plans to initiate a third Phase 2a clinical...
Profire Energy Sets Fourth Quarter and Full Fiscal Year 2023 Call for Thursday, March 14,2024 at 8:30 a.m. ET
28 févr. 2024 13h00 HE
|
Profire Energy, Inc.
LINDON, Utah, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the "Company") that provides solutions which enhance the efficiency, safety, and...
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 févr. 2024 05h50 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today reported financial results for the quarter and year ended December 31, 2023, and provided a business update.
Churchill Downs Incorporated Reports 2023 Fourth Quarter and Full Year Results
21 févr. 2024 16h01 HE
|
Churchill Downs Incorporated
LOUISVILLE, Ky., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (Nasdaq: CHDN) (the “Company”, “CDI”) today reported business results for the quarter and full year ended December 31,...
CompoSecure Schedules Fourth Quarter and Full Year 2023 Conference Call for March 6th at 5:00 p.m. ET
21 févr. 2024 08h30 HE
|
CompoSecure, Inc.
SOMERSET, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Wednesday,...
Niu Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on Mar 18, 2024
19 févr. 2024 04h00 HE
|
NIU Technologies
BEIJING, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced that it will...
Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
16 févr. 2024 08h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced that it will report its fourth quarter and full year financial results and provide a business update on Tuesday, February 27, 2024.
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2023
15 févr. 2024 08h00 HE
|
Integer Holdings Corporation
~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 9% to 11% sales growth in 2024 with expanding margins ~ PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer...
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
15 févr. 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
IPG Photonics Announces Fourth Quarter 2023 Financial Results
13 févr. 2024 08h00 HE
|
IPG Photonics Corporation
Continued Growth in Welding and Medical Applications Working Capital Discipline Resulted in Strong Cash Flow From Operations MARLBOROUGH, Mass. , Feb. 13, 2024 (GLOBE NEWSWIRE) -- IPG...